| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/24/2008 | WO2008155594A2 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 12/24/2008 | WO2008155468A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008155467A1 Transmembrane prostatic acid phosphatase |
| 12/24/2008 | WO2008155441A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008155421A2 Indolin-2-ones and aza-indolin-2-ones |
| 12/24/2008 | WO2008155387A2 Anti-igf antibodies that bind to igf-1 and igf-2 but not to insulin |
| 12/24/2008 | WO2008155378A1 Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1h-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline |
| 12/24/2008 | WO2008155141A2 Novel facultative catonic sterols |
| 12/24/2008 | WO2008155140A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 12/24/2008 | WO2008154905A2 Modifications of the histone deacetylase inhibitor suberoylanilide hydroxamic acid |
| 12/24/2008 | WO2008154868A1 Capsid proteins and uses therefore |
| 12/24/2008 | WO2008154867A1 Material with immunogenicity |
| 12/24/2008 | WO2008154801A1 A trans-cinnamic acid derivative, its preparation method and the use |
| 12/24/2008 | WO2008154719A1 Recombinant human interferon-like proteins |
| 12/24/2008 | WO2008130704A3 PDGFRβ-SPECIFIC INHIBITORS |
| 12/24/2008 | WO2008125839A3 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
| 12/24/2008 | WO2008124524A3 Aryl sulfonamide compounds as modulators of the cck2 receptor |
| 12/24/2008 | WO2008124097A3 Salts of isophosphoramide mustard and analogs thereof |
| 12/24/2008 | WO2008121261A3 Prodrugs of triciribin suitable for treatment of tumors and cancer |
| 12/24/2008 | WO2008112840A3 Novel composition and methods for the treatment of immune related diseases |
| 12/24/2008 | WO2008089436A3 Crystalline forms of histone deacetylase inhibitors |
| 12/24/2008 | WO2008086807A3 Mediated cellular delivery of lna oligonucleotides |
| 12/24/2008 | WO2008086014A3 Bis-aryl amide derivatives useful for the treatment of cancer |
| 12/24/2008 | WO2008060372A3 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 12/24/2008 | WO2008010991A3 Methods and compositions for the treatment of cancer |
| 12/24/2008 | WO2007140002A3 Method for treating non-hodgkin's lymphoma |
| 12/24/2008 | EP2006379A1 High functional bispecific antibody |
| 12/24/2008 | EP2006302A2 Protein complex and process for production thereof |
| 12/24/2008 | EP2005996A2 Immunotherapeutic combination for the treatment of tumors |
| 12/24/2008 | EP2005966A1 Survivin-derived peptides and use thereof |
| 12/24/2008 | EP2005965A1 Water having anticancer action and method for producing the same |
| 12/24/2008 | EP2005961A1 Method of optimizing the treatment of chronic myeloid leukemia with Abl tyrosine kinase inhibitors |
| 12/24/2008 | EP2005956A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical |
| 12/24/2008 | EP2005955A1 Formulation of unsaturated salt of ampelopsin and its application |
| 12/24/2008 | EP2005954A2 Kit for cancer therapy and pharmaceutical composition for cancer therapy |
| 12/24/2008 | EP2005944A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 12/24/2008 | EP2005162A2 Screening method |
| 12/24/2008 | EP2004696A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 12/24/2008 | EP2004693A2 Compositions and methods of use for antibodies of c-met |
| 12/24/2008 | EP2004687A1 Methods for damaging cells using effector functions of anti-cdh3 antibodies |
| 12/24/2008 | EP2004656A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions |
| 12/24/2008 | EP2004655A1 Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4 l)-1-oxo-2,6-dihydro-1h-ý1,2¨diazepinoý4,5,6-cd¨indol-8-yl)acetamide |
| 12/24/2008 | EP2004654A2 Kinase antagonists |
| 12/24/2008 | EP2004653A1 3-SUBSTITUTED N-(ARYL- OR HETEROARYL)-PYRAZO[1,5-a]PYRIMIDINES AS KINASE INHIBITORS |
| 12/24/2008 | EP2004651A2 Novel cyclobutyl compounds as kinase inhibitors |
| 12/24/2008 | EP2004649A2 Phenolic hydrazone macrophage migration inhibitory factor inhibitors |
| 12/24/2008 | EP2004648A1 Purine compounds as hsp90 protein inhibitors for the treatment of cancer |
| 12/24/2008 | EP2004645A2 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 12/24/2008 | EP2004642A1 Bifunctional polyazamacrocyclic chelating agents |
| 12/24/2008 | EP2004631A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases |
| 12/24/2008 | EP2004625A2 C-met protein kinase inhibitors for the treatment of proliferative disorders |
| 12/24/2008 | EP2004623A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors |
| 12/24/2008 | EP2004618A1 Telomerase inhibitors |
| 12/24/2008 | EP2004617A2 Ceramide kinase modulation |
| 12/24/2008 | EP2004614A1 Tetrahalogenated compounds useful as inhibitors of angiogenesis |
| 12/24/2008 | EP2004597A2 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 12/24/2008 | EP2004236A2 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis |
| 12/24/2008 | EP2004228A1 Methods for damaging cells using effector functions of anti-epha4 antibodies |
| 12/24/2008 | EP2004218A2 Her-2/neu multi-peptide vaccine |
| 12/24/2008 | EP2004205A1 Inorganic selenium for treatment of benign tumors |
| 12/24/2008 | EP2004180A2 Use of a kinase inhibitor for the treatment of particular resistant tumors |
| 12/24/2008 | EP2004179A1 Medicament, cosmetic or food product comprising an indol compound, the use thereof and the method of isolation thereof from sauerkraut |
| 12/24/2008 | EP2004175A2 Anti-cancer activity augmentation compounds and formulations and methods of use thereof |
| 12/24/2008 | EP2004170A1 Treatment of hematological malignancies with fts and a bcr-abl tyrosine kinase inhibitor |
| 12/24/2008 | EP2004165A2 Synergistic combinations of anticancer agents for treating cancer |
| 12/24/2008 | EP2004163A2 Combinations comprising mtor inhibitors for treating cancer |
| 12/24/2008 | EP2004156A2 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 12/24/2008 | EP1603555B1 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 12/24/2008 | EP1558242B1 Combination comprising docetaxel and a cdk inhibitor |
| 12/24/2008 | EP1549340B1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 12/24/2008 | EP1501503B1 Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatment of central nervous system disturbances |
| 12/24/2008 | EP1368061B1 Fusion cells and cytokine compositions for treatment of disease |
| 12/24/2008 | EP1328291B1 Viruses targeted to hypoxic cells and tissues |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | EP1017399B1 Camptothecin analogs and methods of preparation thereof |
| 12/24/2008 | EP1003773B1 Ctl epitopes of epstein-barr virus |
| 12/24/2008 | EP0909277B2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 12/24/2008 | DE69922977C5 Neue Kristallmodifikation von Torasemid New crystal modification of torasemide |
| 12/24/2008 | DE202008011721U1 Pflanzliche Zusammensetzung zur Behandlung von Krebs Herbal composition for the treatment of cancer |
| 12/24/2008 | DE112007000079T5 Neuartige Bis-Pyrrolo[2,1-c][1,4]benzodiazepin-anthrachinon Konjugate und ein Verfahren zu deren Herstellung Novel bis-pyrrolo [2,1-c] [1,4] benzodiazepine-anthraquinone conjugates and a method for their preparation |
| 12/24/2008 | DE102007029042A1 Pharmazeutische Zusammensetzung mit einem Trihydroxychromenone-Derivate A pharmaceutical composition comprising a Trihydroxychromenone derivatives |
| 12/24/2008 | DE102007028521A1 Indazolamidderivate Indazolamidderivate |
| 12/24/2008 | DE102007028515A1 6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate 6- (pyrrolopyridinyl) -pyrimidinyl-2-amine derivatives |
| 12/24/2008 | DE102007028198A1 New alkyl-ketone compounds are histone deacetylase inhibitors, useful to treat e.g. cancer, hematologic or solid tumors, non-Hodgkins tumors, T-cell lymphoma, type I diabetes or Hashimoto's thyroiditis, and to modulate e.g. cell cycle |
| 12/24/2008 | CN101331229A Immunostimulatory oligoribonucleotides |
| 12/24/2008 | CN101331151A Means and methods for the treatment of tumorous diseases |
| 12/24/2008 | CN101331139A New crystalline form of vinflunine ditartrate |
| 12/24/2008 | CN101331137A Antitumour compounds |
| 12/24/2008 | CN101331135A Novel imidazopyrazines as cyclin dependent kinase inhibitors |
| 12/24/2008 | CN101331133A Sulphonamidoaniline derivatives being Janus kinases inhibitors |
| 12/24/2008 | CN101331129A Dibenzonaphthyridine derivatives and methods of use thereof |
| 12/24/2008 | CN101331126A Benzimidazole thiophene compounds as PLK modulators |
| 12/24/2008 | CN101331123A Benzamide compounds useful as histone deacetylase inhibitors |
| 12/24/2008 | CN101330925A Therapeutic methods for inhibiting tumor growth with D114 antagonists |
| 12/24/2008 | CN101330918A Pyridopyrazine derivatives and use thereof as modulators of the signal transduction paths |
| 12/24/2008 | CN101330917A Fixed ratio drug combination treatments for solid tumors |
| 12/24/2008 | CN101330912A Pharmaceutical composition of docetaxel, preparation method and purpose |
| 12/24/2008 | CN101330839A Extract liquid containing -cryptoxanthin ingredient, and food or beverage and soap or cosmetic each containing the extract liquid |
| 12/24/2008 | CN101328497A Polar maritime actinomycete AFN1007 generating antineoplastic activity material |
| 12/24/2008 | CN101328476A Nucleic acid molecule NRN1SR32 and use thereof in anti-cancer medicine preparation |